It was shown that CD36 levels decreased over the course of the cellular differentiation of CSCs [4716 Conversely, the downregulation of CD36 via an siRNA treatment was shown to result in loss of self-renewal and tumor initiating ability [16]. This evidence concerns the gene CD36 and neoplasm.